Xdemvy Solution/ Drops
Product Images NDC 81942-125

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Xdemvy (NDC 81942-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tarsus Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xdemvy 01)

Chemical Structure (Xdemvy 01)
Chemical structure diagram of Lotilaner, the active ingredient in XDEMVY ophthalmic solution 2.5 mg/mL. The structure displays atoms and bonds forming the molecular framework of the compound.*
FDA Label Image

Figure 1 (Xdemvy 02)

Figure 1 (Xdemvy 02)
Bar chart depicting the proportion of patients with 2 or fewer collarettes over time comparing XDEMVY (lotilaner ophthalmic solution 2.5 mg/mL) and vehicle. The x-axis shows days 8, 15, 22, and 43, and the y-axis shows percentage of patients. XDEMVY demonstrates increasing proportions from 2% on day 8 to 44% on day 43, while vehicle proportions remain low, peaking at 7% on day 43.*
FDA Label Image

Figure 2 (Xdemvy 03)

Figure 2 (Xdemvy 03)
A bar chart comparing the proportion of patients with 2 or fewer collarettes over time between XDEMVY and Vehicle. The x-axis shows days 8, 15, 22, and 43, while the y-axis represents the percentage of patients. XDEMVY shows increasing percentages from 4% on day 8 to 55% on day 43, consistently higher than Vehicle, which ranges from 3% to 12%.*
FDA Label Image

Principal Display Panel (1.5 mL Bottle Carton)

Principal Display Panel (1.5 mL Bottle Carton)
Packaging label for XDEMVY (lotilaner ophthalmic solution) 0.25% (2.5 mg/mL) in a 15 mL ophthalmic solution intended for topical application in the eye. The label indicates it is a physician sample supplied by Tarsus Pharmaceuticals, Inc., with storage instructions and a list of inactive ingredients. The label includes branding elements, barcodes, and manufacturer information for Tarsus Pharmaceuticals, Irvine, CA.*
FDA Label Image

Principal Display Panel (10 mL Bottle Carton)

Principal Display Panel (10 mL Bottle Carton)
Packaging label for XDEMVY (lotilaner ophthalmic solution) 0.25% (2.5 mg/mL) 10 mL solution by Tarsus Pharmaceuticals, Inc. Label shows active and inactive ingredients, storage instructions, and directions for topical eye application. Includes NDC 81942-125-01, barcodes, and labeler information with trademarked brand name and dosing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.